Related Experiment Video
Updated: Feb 10, 2026

Light/dark Transition Test for Mice
Published on: November 13, 2006
Dependence receptors - the dark side awakens
Ana-Maria Negulescu1, Patrick Mehlen1
1Apoptosis, Cancer and Development Laboratory - Equipe labelisée "La Ligue", LabEx DEVweCAN, INSERM U1052 - CNRS UMR5286, Centre de Cancérologie de Lyon, Centre Léon Bérard, Université Claude Bernard Lyon-1, Université de Lyon, France.
Abstract:
Transmembrane receptors are usually seen as on and off switches: when the specific ligand is bound, the receptor is on and transduces a downstream signal, whereas when the ligand is absent, the receptor is off. Over the last two decades several reports have argued for an alternative view where some receptors, depending on the context, will be active both in the presence and in the absence of ligand, being sort of onA and onB switch rather than on and off. These receptors have been named dependence receptors (DR) and they share the ability to actively trigger cell death when unbound by their respective ligands. DRs have been shown to be important guardians of tissue homeostasis. In pathological settings such as cancer, DRs are seen as tumour suppressors and a clinical trial is ongoing to assay whether these DRs can be used to provide clinical benefit by triggering cancer cell death. In this review we are reviewing this functional family of receptors and underlying their promising potential for targeted therapy against cancer.
Insights
Dependence receptors (DRs) are a unique class of transmembrane receptors that trigger cell death when unbound. This review explores their role in tissue homeostasis and potential as cancer therapeutics.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- Transmembrane receptors traditionally function as binary on/off switches.
- Emerging evidence suggests some receptors exhibit dual activity, dependent on ligand presence.
- Dependence receptors (DRs) are a distinct class of receptors with unique signaling properties.
Purpose of the Study:
- To review the functional family of dependence receptors (DRs).
- To elucidate the mechanisms underlying DRs' dual activity.
- To explore the therapeutic potential of DRs in cancer treatment.
Main Methods:
- Literature review of studies on dependence receptors.
- Analysis of signaling pathways associated with DRs.
- Examination of DRs' role in tissue homeostasis and cancer.
Main Results:
- DRs actively trigger cell death when unbound by their ligands.
- DRs function as crucial regulators of tissue homeostasis.
- Dysregulation of DRs is implicated in pathological conditions like cancer.
Conclusions:
- DRs represent a novel class of receptors with context-dependent activity.
- DRs act as tumor suppressors, offering a new avenue for cancer therapy.
- Targeting DRs holds promise for developing novel cancer treatments.
More Related Videos
12:03Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors
Published on: June 7, 2016
10:19High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum
Published on: November 23, 2013
Related Concept Videos
Dark Triad and Person Perception
Frequency-dependent Selection
Internal Receptors
Drug Dependence
Receptor-mediated Endocytosis
Contact-dependent Signaling
Gap Junctions
In animal cells, gap junctions are formed...